Unicycive Therapeutics, Inc SC 13G/A

EXHIBIT 1

 

JOINT ACQUISITION STATEMENT

PURSUANT TO SECTION 240.13d-1(k)

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.

 

 

 

Dated:   February 11, 2022

 
 

  

Altium Capital Management, LP

 
       
  By: /s/ Jacob Gottlieb  
  Name: Jacob Gottlieb  
  Title: CEO  
       
       
 

Altium Growth Fund, LP

 

By: Altium Growth GP, LLC

Its: General Partner

 
     
  Signature: /s/ Jacob Gottlieb  
  Name: Jacob Gottlieb  
  Title: Managing Member of Altium Growth GP, LLC  
       
   
  Altium Growth GP, LLC  
       
  By: /s/ Jacob Gottlieb  
  Name: Jacob Gottlieb  
  Title: Managing Member